Clinical trials
Recruiting Cholangiocarcinoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 18 |
| 2025 | 14 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 5 |
| Fudan University | 4 |
| Shanghai Zhongshan Hospital | 3 |
| The First Affiliated Hospital with Nanjing Medical University | 3 |
| Tianjin Medical University Cancer Institute and Hospital | 3 |
| West China Hospital | 3 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2 |
| Chongqing Precision Biotech Co., Ltd | 2 |
| Peking Union Medical College Hospital | 2 |
| Anhui Provincial Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 57 |
| Gallbladder Neoplasms | 9 |
| Biliary Tract Neoplasms | 7 |
| Breast Neoplasms | 7 |
| Carcinoma, Hepatocellular | 7 |
| Stomach Neoplasms | 7 |
| Lung Neoplasms | 6 |
| Pancreatic Neoplasms | 6 |
| Endometrial Neoplasms | 4 |
| Esophageal Neoplasms | 4 |
Trials
Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.